Page last updated: 2024-08-18

methyleugenol and Leishmaniasis, Visceral

methyleugenol has been researched along with Leishmaniasis, Visceral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charan Raja, MR; Chellappan, D; Debnath, J; Kar Mahapatra, S; Velappan, AB	1

Other Studies

1 other study(ies) available for methyleugenol and Leishmaniasis, Visceral

Article	Year
Eugenol derived immunomodulatory molecules against visceral leishmaniasis. European journal of medicinal chemistry, 2017, Oct-20, Volume: 139 Topics: Animals; Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Eugenol; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; RAW 264.7 Cells; Structure-Activity Relationship	2017

Article

Year

Eugenol derived immunomodulatory molecules against visceral leishmaniasis.

European journal of medicinal chemistry, 2017, Oct-20, Volume: 139

Topics: Animals; Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Eugenol; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Parasitic Sensitivity Tests; RAW 264.7 Cells; Structure-Activity Relationship

2017